Advertisement
NeurAxis Inc. (NRXS)
NASDAQ: NRXS
· Real-Time Price · USD
2.20
-0.10 (-4.35%)
At close: Apr 29, 2025, 9:41 AM
-4.35% (1D)
| Bid | 2.11 |
| Market Cap | 15.87M |
| Revenue (ttm) | 2.69M |
| Net Income (ttm) | -8.24M |
| EPS (ttm) | -1.22 |
| PE Ratio (ttm) | -1.8 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.46 |
| Volume | 974 |
| Avg. Volume (20D) | 26,929 |
| Open | 2.31 |
| Previous Close | 2.30 |
| Day's Range | 2.20 - 2.31 |
| 52-Week Range | 1.33 - 3.78 |
| Beta | 4.21 |
About NRXS
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. ...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 9, 2023
Employees 21
Stock Exchange NASDAQ
Ticker Symbol NRXS
Website https://neuraxis.com
Advertisement
5 months ago
+26.4%
Neuraxis shares are trading higher after the compa...
Unlock content with
Pro Subscription
6 months ago
+5.07%
Neuraxis shares are trading higher after the company announced a new CPT category I code for percutaneous electrical nerve field stimulation.
